Back to search

Poland· PL-100008889

Barium sulfuricum Medana

A bariumsulfat mit suspensions-stabilisator product containing barii sulfas, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 8 of our 19 countries.

ATC V08BA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBarium sulfuricum MedanaATCV08BA01REGISTER NO.PL-100008889PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Bariumsulfat mit suspensions-stabilisator is registered in 8 of 19 countries.

Countries holding a registration under ATC V08BA01 (bariumsulfat mit suspensions-stabilisator), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Bariumsulfat mit suspensions-stabilisator · ATC V08BA01

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Barii sulfas
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Country
Poland (PL)
ATC code
V08BA01
ATC class
Bariumsulfat mit Suspensions-Stabilisator
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990276516
  • gtin
    05909990044955
  • gtin
    05909990044948

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bariumsulfat mit suspensions-stabilisator in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bariumsulfat mit suspensions-stabilisator products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Micropaque, Micropaque Ct
  • Belgium · Micropaque Scanner, Micropaque Suspensie
  • Bulgaria · Дк-Бар
  • Czechia · Micropaque, Micropaque Ct
  • Germany · Micropaque, Micropaque Ct
  • Denmark · Microtrast
  • Spain · Barigraf, Barigraf Ad
  • France · Micropaque, Micropaque Scanner
  • United Kingdom (Northern Ireland) · E-Z-Cat, E-Z-Hd
  • Hungary · Micropaque, Micropaque Ct
  • Ireland · Maxibar
  • Italy · Prontobario Colon, Prontobario Hd
  • Luxembourg · Micropaque Scanner, Micropaque Suspension
  • Netherlands · E-Z-Cat, E-Z-Hd
  • Portugal · Barigraf Tac, E-Z-Cat
  • Romania · Sulfat De Bariu Meduman
  • Slovakia · Micropaque, Micropaque Ct

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/53bda2d7-7931-47f2-bf52-c734d57ad251
GET /v1/drugs/53bda2d7-7931-47f2-bf52-c734d57ad251?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zawiesina doustna i doodbytnicza",
  "source": "urpl",
  "strength": "1 g/ml",
  "packaging": "05909990276516 ¦ Lz ¦ Skasowane ¦ 1737\n1 op. 200 ml\n05909990044955 ¦ Lz ¦ Skasowane ¦ 35681\n1 butelka 200 ml\n05909990044948 ¦ Lz ¦ 44577\n1 butelka 200 ml",
  "substance": "Barii sulfas 200 g",
  "common_name": "Barii sulfas",
  "pl_product_id": "100008889",
  "pozwolenie_nr": "02765",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about bariumsulfat mit suspensions-stabilisator.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.